These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 35978520)

  • 21. Taraxacum mongolicum extract inhibited malignant phenotype of triple-negative breast cancer cells in tumor-associated macrophages microenvironment through suppressing IL-10 / STAT3 / PD-L1 signaling pathways.
    Deng XX; Jiao YN; Hao HF; Xue D; Bai CC; Han SY
    J Ethnopharmacol; 2021 Jun; 274():113978. PubMed ID: 33716082
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of macrophages during breast cancer development and response to chemotherapy.
    Tao S; Zhao Z; Zhang X; Guan X; Wei J; Yuan B; He S; Zhao D; Zhang J; Liu Q; Ding Y
    Clin Transl Oncol; 2020 Nov; 22(11):1938-1951. PubMed ID: 32279178
    [TBL] [Abstract][Full Text] [Related]  

  • 23. LncRNA GNAS-AS1 facilitates ER+ breast cancer cells progression by promoting M2 macrophage polarization via regulating miR-433-3p/GATA3 axis.
    Liu SQ; Zhou ZY; Dong X; Guo L; Zhang KJ
    Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32538432
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Wound healing-like immune program facilitates postpartum mammary gland involution and tumor progression.
    Martinson HA; Jindal S; Durand-Rougely C; Borges VF; Schedin P
    Int J Cancer; 2015 Apr; 136(8):1803-13. PubMed ID: 25187059
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transfer of miRNA in tumor-derived exosomes suppresses breast tumor cell invasion and migration by inducing M1 polarization in macrophages.
    Moradi-Chaleshtori M; Shojaei S; Mohammadi-Yeganeh S; Hashemi SM
    Life Sci; 2021 Oct; 282():119800. PubMed ID: 34245773
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phagocytic function of tumor-associated macrophages as a key determinant of tumor progression control: a review.
    Lecoultre M; Dutoit V; Walker PR
    J Immunother Cancer; 2020 Dec; 8(2):. PubMed ID: 33335026
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dealing with Macrophage Plasticity to Address Therapeutic Challenges in Head and Neck Cancers.
    Furgiuele S; Descamps G; Cascarano L; Boucq A; Dubois C; Journe F; Saussez S
    Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35742830
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of NFATc1/c-myc/PKM2/IL-10 axis in activating cervical cancer tumor-associated M2 macrophage polarization to promote cervical cancer progression.
    Tan J; Yang L; Zhao H; Ai Y; Ren L; Zhang F; Dong W; Shi R; Sun D; Feng Y
    Exp Cell Res; 2022 Apr; 413(2):113052. PubMed ID: 35122827
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tumor-associated macrophages secrete CC-chemokine ligand 2 and induce tamoxifen resistance by activating PI3K/Akt/mTOR in breast cancer.
    Li D; Ji H; Niu X; Yin L; Wang Y; Gu Y; Wang J; Zhou X; Zhang H; Zhang Q
    Cancer Sci; 2020 Jan; 111(1):47-58. PubMed ID: 31710162
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Redirecting tumor-associated macrophages to become tumoricidal effectors as a novel strategy for cancer therapy.
    Zheng X; Turkowski K; Mora J; Brüne B; Seeger W; Weigert A; Savai R
    Oncotarget; 2017 Jul; 8(29):48436-48452. PubMed ID: 28467800
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Shaping Polarization Of Tumor-Associated Macrophages In Cancer Immunotherapy.
    Gao J; Liang Y; Wang L
    Front Immunol; 2022; 13():888713. PubMed ID: 35844605
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tissue-resident macrophages - early passengers or drivers in the tumor niche?
    Vogel A; Weichhart T
    Curr Opin Biotechnol; 2023 Oct; 83():102984. PubMed ID: 37572419
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Macrophage Biology and Mechanisms of Immune Suppression in Breast Cancer.
    Mehta AK; Kadel S; Townsend MG; Oliwa M; Guerriero JL
    Front Immunol; 2021; 12():643771. PubMed ID: 33968034
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diverse macrophages polarization in tumor microenvironment.
    Rhee I
    Arch Pharm Res; 2016 Nov; 39(11):1588-1596. PubMed ID: 27562774
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metabolically activated adipose tissue macrophages link obesity to triple-negative breast cancer.
    Tiwari P; Blank A; Cui C; Schoenfelt KQ; Zhou G; Xu Y; Khramtsova G; Olopade F; Shah AM; Khan SA; Rosner MR; Becker L
    J Exp Med; 2019 Jun; 216(6):1345-1358. PubMed ID: 31053611
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Impact of the Tumor Microenvironment on Macrophage Polarization in Cancer Metastatic Progression.
    Wang H; Yung MMH; Ngan HYS; Chan KKL; Chan DW
    Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34207286
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Wnt5a-induced M2 polarization of tumor-associated macrophages via IL-10 promotes colorectal cancer progression.
    Liu Q; Yang C; Wang S; Shi D; Wei C; Song J; Lin X; Dou R; Bai J; Xiang Z; Huang S; Liu K; Xiong B
    Cell Commun Signal; 2020 Mar; 18(1):51. PubMed ID: 32228612
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reversing the polarization of tumor-associated macrophages inhibits tumor metastasis.
    Yuan R; Li S; Geng H; Wang X; Guan Q; Li X; Ren C; Yuan X
    Int Immunopharmacol; 2017 Aug; 49():30-37. PubMed ID: 28550732
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Exosome-mediated miR-33 transfer induces M1 polarization in mouse macrophages and exerts antitumor effect in 4T1 breast cancer cell line.
    Moradi-Chaleshtori M; Bandehpour M; Heidari N; Mohammadi-Yeganeh S; Mahmoud Hashemi S
    Int Immunopharmacol; 2021 Jan; 90():107198. PubMed ID: 33249048
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anti-inflammatory signaling by mammary tumor cells mediates prometastatic macrophage polarization in an innovative intraductal mouse model for triple-negative breast cancer.
    Steenbrugge J; Breyne K; Demeyere K; De Wever O; Sanders NN; Van Den Broeck W; Colpaert C; Vermeulen P; Van Laere S; Meyer E
    J Exp Clin Cancer Res; 2018 Aug; 37(1):191. PubMed ID: 30111338
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.